Guruprasad, Puneeth
Ramasubramanian, Ranjani
Nason, Siena
Carturan, Alberto
Liu, Shan
Paruzzo, Luca https://orcid.org/0000-0002-6505-0194
Hornet, Vladlena https://orcid.org/0009-0002-1712-4969
Plesset, Jacqueline
Patel, Ruchi P.
Bhoj, Vijay
Beatty, Gregory L.
Ruella, Marco https://orcid.org/0000-0003-4301-5811
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R00CA212302)
U.S. Department of Health & Human Services | National Institutes of Health (R01-37-CA262362-03)
Article History
Received: 6 September 2024
Accepted: 20 May 2025
First Online: 25 July 2025
Competing interests
: M.R. reports receiving grants from viTToria Biotherapeutics, AbClon and Oxford Nanoimaging. He also reports nonfinancial support (equipment) from Beckman Coulter, LUMICKS and Curiox Biosystems. In addition, M.R. serves on the Scientific Advisory Boards of viTToria Biotherapeutics, AbClon, Acera and LUMICKS. He receives consulting fees from GLG and Guidepoint and holds CAR T-related patents managed by the University of Pennsylvania, which are partly licensed to Novartis, Kite and viTToria Biotherapeutics. All other authors declare no competing interests.